Wednesday, June 30, 2021

The value of interdisciplinary treatment for sickness absence in chronic pain: a nationwide register‐based cohort study

ABSTRACT

Background

Interdisciplinary treatment (IDT) is an internationally recommended intervention for chronic pain, despite inconclusive evidence of its effects on sickness absence.

Methods

With data from 25,613 patients in Swedish specialist healthcare, we compared sickness absence, in the form of both sick leave and disability pensions, over a five-year period between patients either allocated to an IDT program or to treatment-as-usual (controls). To obtain population-average estimates, a Markov multistate model with theory-based inverse probability weights was used to compute both the proportion of patients on sickness absence and the total sickness absence duration.

Results

IDT patients were more likely than controls to receive sickness absence benefits at any given time (baseline: 49% vs. 46%; 5-year follow-up: 36% vs. 35%), and thereby also had a higher total duration, with a mean (95% CI) of 67 (87, 48) more days than controls over the five-year period. Intriguingly, sick leave was higher in IDT patients [563 (552, 573) vs. 478 (466, 490) days], whereas disability pension was higher in controls [152 (144, 160) vs. 169 (161, 178) days].

Conclusion

In line with much of the currently available research, we found no support for IDT decreasing sickness absence in chronic pain patients.



from Wiley: European Journal of Pain: Table of Contents https://ift.tt/3ho4fDa
via IFTTT

No comments:

Post a Comment